Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
6 Results for "
postmenopausal breast cancer
" in MedChemExpress (MCE) Product Catalog:
Products (6)
6 Results for "postmenopausal breast cancer" in MCE Product Catalog:
6
Target:
Research Areas:
Lasofoxifene (CP-336156) is an orally active and selective estrogen receptor modulator (SERM). Lasofoxifene exhibits an anti-osteoporotic function and also inhibits primary tumor growth and metastases. Lasofoxifene can be used for research of breast cancer and postmenopausal osteoporosis .
6
Target:
Research Areas:
Lasofoxifene (CP-336156) tartrate is an orally active and selective estrogen receptor modulator (SERM) . Lasofoxifene tartrate exhibits an anti-osteoporotic function and also inhibits primary tumor growth and metastases. Lasofoxifene tartrate can be used for the research of breast cancer and postmenopausal osteoporosis .
Cat. No.: HY-159741
CAS No.: 105051-87-4
Synonyms: FCE 24928
Target:
Research Areas:
Minamestane (FCE 24928) is a selective and competitive aromatase inhibitor with an IC50 value of 45.7 nM. Minamestane is promising for research of postmenopausal breast cancer .
Cat. No.: HY-187622
CAS No.: 148714-92-5
Target:
Research Areas:
Org 33201 is an orally active and selective Aromatase inhibitor with an IC50 of 2.2 nM. Org 33201 inhibits the activity of Aromatase by binding to its heme iron. Org 33201 can be used in the study of estrogen-dependent diseases (such as postmenopausal breast cancer) .
Cat. No.: HY-A0037R
CAS No.: 180916-16-9
Synonyms: CP-336156 (Standard)
Research Areas:
Lasofoxifene (Standard) is the analytical standard of Lasofoxifene. This product is intended for research and analytical applications. Lasofoxifene (CP-336156) is an orally active and selective estrogen receptor modulator (SERM). Lasofoxifene exhibits an anti-osteoporotic function and also inhibits primary tumor growth and metastases. Lasofoxifene can be used for research of breast cancer and postmenopausal osteoporosis .
Cat. No.: HY-117076A
CAS No.: 61665-15-4
Synonyms: (R)-R 2858; RU 16117
Target:
Research Areas:
(R)-Moxestrol ((R)-R 2858; RU 16117) is an orally active weak partial agonist-antagonist of estrogen receptor (ER). (R)-Moxestrol binds to estrogen receptor to form a rapidly dissociating complex, reduces the levels of estrogen and prolactin receptor, exerts weak estrogenic effects at low doses, and displays anti-estrogenic effects at high doses or when competing with Estradiol (E2) (HY-B0141). (R)-Moxestrol can be used in research related to breast cancer and postmenopausal estrogen deficiency (menopausal symptoms, severe osteoporosis) .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
